Adelphi Capital LLP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Adelphi Capital LLP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q4 2020$138,046,000
-6.5%
7,584,930
-8.3%
26.79%
-6.6%
Q3 2020$147,612,000
-10.1%
8,274,227
-9.6%
28.67%
-20.4%
Q2 2020$164,172,000
+16.5%
9,156,315
-1.4%
36.01%
+6.5%
Q1 2020$140,909,000
-20.3%
9,282,543
+3.6%
33.82%
+0.2%
Q4 2019$176,757,000
+14.3%
8,958,784
-0.4%
33.75%
+1.0%
Q3 2019$154,650,000
+10.2%
8,991,290
+13.4%
33.43%
+1.5%
Q2 2019$140,381,000
-25.7%
7,931,116
-14.4%
32.92%
-15.9%
Q1 2019$188,841,0009,270,53539.13%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2020
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders